SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-19-064709
Filing Date
2019-03-06
Accepted
2019-03-06 07:53:32
Documents
3
Period of Report
2019-03-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d715936d8k.htm 8-K 34037
2 EX-99.1 d715936dex991.htm EX-99.1 10876
3 GRAPHIC g715936g73s11.jpg GRAPHIC 7554
  Complete submission text file 0001193125-19-064709.txt   56932
Mailing Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 784 MEMORIAL DRIVE CAMBRIDGE MA 02139 6174531000
INFINITY PHARMACEUTICALS, INC. (Filer) CIK: 0001113148 (see all company filings)

IRS No.: 330655706 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31141 | Film No.: 19661272
SIC: 2834 Pharmaceutical Preparations